Smoking at diagnosis significantly decreases 5-year cancer-specific survival in a population-based cohort of 18 166 colon cancer patients

Alimentary Pharmacology and Therapeutics

Volumn 45, Issue 6, 2017, Pages 788-800

  Sharp, L ^a   McDevitt, J ^b   Brown, C ^b   Comber, H ^b  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b NATIONAL CANCER REGISTRY IRELAND   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER PROGNOSIS; CANCER REGISTRY; CANCER SPECIFIC SURVIVAL; CANCER SURGERY; COHORT ANALYSIS; COLON ADENOCARCINOMA; COLON CANCER; CONTROLLED STUDY; FEMALE; HUMAN; IRELAND; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; SMOKING; COLON TUMOR; HEALTH SURVEY; MORTALITY; PROCEDURES; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; SURVIVAL RATE; TIME FACTOR; TRENDS;

ADULT; AGED; COHORT STUDIES; COLONIC NEOPLASMS; FEMALE; HUMANS; MALE; MIDDLE AGED; POPULATION SURVEILLANCE; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; SMOKING; SURVIVAL RATE; TIME FACTORS;

EID: 85012892260     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/apt.13944     Document Type: Article

References (63)

1. Ferlay J, Soerjomataram I, Ervik M, et al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer; 2013. Available at: http://globocan.iarc.fr (accessed 3 June 2016).
2. Aleksandrova K, Pischon T, Buijsse B, et al. Adult weight change and risk of colorectal cancer in the European Prospective Investigation into Cancer and Nutrition. Eur J Cancer 2013; 49: 3526–36.
3. Cheng J, Chen Y, Wang X, et al. Meta-analysis of prospective cohort studies of cigarette smoking and the incidence of colon and rectal cancers. Eur J Cancer Prev 2015; 24: 6–15.
4. Cong YJ, Gan Y, Sun HL, et al. Association of sedentary behaviour with colon and rectal cancer: a meta-analysis of observational studies. Br J Cancer 2014; 110: 817–26.
5. Odegaard AO, Koh W-P, Yuan J-M. Combined lifestyle factors and risk of incident colorectal cancer in a Chinese population. Cancer Prev Res 2013; 6: 360–7.
6. WCFR/AICR. Colorectal Cancer 2011 Report - Food, Nutrition, Physical Activity, and the Prevention of Colorectal Cancer. Continuous Update Project. London: World Cancer Research Fund & American Institute for Cancer Research; 2011.
7. Pelser C, Arem H, Pfeiffer RM, et al. Prediagnostic lifestyle factors and survival after colon and rectal cancer diagnosis in the National Institutes of Health (NIH)-AARP Diet and Health Study. Cancer 2014; 120: 1540–7.
8. Prizment AE, Flood A, Anderson KE, et al. Survival of women with colon cancer in relation to precancer anthropometric characteristics: the Iowa Women's Health Study. Cancer Epidemiol Biomarkers Prev 2010; 19: 2229–37.
9. Yamauchi M, Lochhead P, Imamura Y, et al. Physical activity, tumor PTGS2 expression, and survival in patients with colorectal cancer. Cancer Epidemiol Biomarkers Prev 2013; 22: 1142–52.
10. US Department of Health and Human Services. The Health Consequences of Smoking—50 Years of Progress. A Report of the Surgeon General. Rockville, MD: US Department of Health and Human Services; 2014.
11. Walter V, Jansen L, Hoffmeister M, et al. Smoking and survival of colorectal cancer patients: systematic review and meta-analysis. Ann Oncol 2014; 25: 1517–25.
12. Mallaina P, Lionis C, Rol H, et al. Smoking cessation and the risk of cardiovascular disease outcomes predicted from established risk scores: results of the Cardiovascular Risk Assessment among Smokers in Primary Care in Europe (CV-ASPIRE) study. BMC Public Health 2013; 13: 362.
13. Boyle T, Fritschi L, Platell C, et al. Lifestyle factors associated with survival after colorectal cancer diagnosis. Br J Cancer 2013; 109: 814–22.
14. McCleary NJ, Niedzwiecki D, Hollis D, et al. Impact of smoking on patients with stage III colon cancer. Cancer 2010; 116: 957–66.
15. Phipps AI, Baron J, Newcomb PA. Prediagnostic smoking history, alcohol consumption, and colorectal cancer survival. Cancer 2011; 117: 4948–57.
16. Phipps AI, Shi Q, Newcomb PA, et al. Associations between cigarette smoking status and colon cnacer prognosis among participants in North Central Cancer Treatmet Group Phase III Trial N0147. J Clin Oncol 2013; 31: 2016–23.
17. National Comprehensive Cancer Network. Clinical Practice Guidelines in Oncology (NCCN Guidelines), Volume 3. Fort Washington, PA: NCCN; 2015.
18. Nickelsen TN, Jørgensen T, Kronborg O. Lifestyle and 30-day complications to surgery for colorectal cancer. Acta Oncol 2005; 44: 218–23.
19. Sharma A, Deeb A-P, Iannuzzi JC, et al. Tobacco smoking and postoperative outcomes after colorectal surgery. Ann Surg 2013; 258: 296–300.
20. Munro AJ, Bentley AHM, Ackland C, et al. Smoking compromises cause-specific survival in patients with operable colorectal cancer. Clin Oncol 2006; 18: 436–40.
21. Dinicola S, Morini V, Coluccia P, et al. Nicotine increases survival in human colon cancer cells treated with chemotherapeutic drugs. Toxicol In Vitro 2013; 27: 2256–63.
22. O'Brien K, Comber H, Sharp L. Completeness of case ascertainment at the Irish National Cancer Registry. Ir J Med Sci 2014; 183: 219–24.
23. Howlader N, Ries LAG, Mariotto AB, et al. Improved estimates of cancer-specific survival rates from population-based data. J Natl Cancer Inst 2010; 102: 1584–98.
24. Kelly A, Teljeur C. A new National Deprivation Index for Health and Health Services Research. Dublin: Small Area Health Research Unit, Trinity College: Dublin; 2004.
25. Sobin LH, Gospodarowicz MK, Wittekind C. TNM Classification of Malignant Tumours. New York: John Wiley & Sons, 2011.
26. National Cancer Intelligence Network. Colorectal Cancer Survival by Stage. NCIN Data Briefing. London: National Cancer Intelligence Network, 2009.
27. Wuxiao ZJ, Zhou HY, Wang KF, et al. A prognostic model to predict survival in stage III colon cancer patients based on histological grade, preoperative carcinoembryonic antigen level and the neutrophil lymphocyte ratio. Asian Pac J Cancer Prev 2014; 16: 747–51.
28. Carlin JB, Galati JC, Royston P. A new framework for managing and analyzing multiply imputed data in Stata. Stata J 2008; 8: 49–67.
29. White IR, Royston P, Wood AM. Multiple imputation using chained equations: issues and guidance for practice. Stat Med 2011; 30: 377–99.
30. van der Heijden GJ, Donders AR, Stijnen T, Moons KG. Imputation of missing values is superior to complete case analysis and the missing-indicator method in multivariable diagnostic research: a clinical example. J Clin Epidemiol 2006; 59: 1102–9.
31. White IR, Carlin JB. Bias and efficiency of multiple imputation compared with complete-case analysis for missing covariate values. Stat Med 2010; 29: 2920–31.
32. Azur MJ, Stuart EA, Frangakis C, Leaf PJ. Multiple imputation by chained equations: what is it and how does it work? Int J Methods Psychiatr Res 2011; 20: 40–9.
33. Sterne J, White IR, Carlin JB, et al. Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls. BMJ 2009; 338: b2393.
34. Rubin DB. Multiple Imputation for Nonresponse in Surveys. New York: John Wiley & Sons, 1987.
35. Grambsch PM, Therneau TM. Proportional hazards tests and diagnostics based on weighted residuals. Biometrika 1994; 81: 515–26.
36. Parast L, Cai T. Landmark risk prediction of residual life for breast cancer survival. Stat Med 2013; 32: 3459–71.
37. Zhu Y, Yang SR, Wang PP, et al. Influence of pre-diagnostic cigarette smoking on colorectal cancer survival: overall and by tumour molecular phenotype. Br J Cancer 2014; 110: 1359–66.
38. Amri R, Brideianou LG, Sylla P, Berger DL. Does active smoking induce hematogenous metastatic spread in colon cancer? Am J Surg 2015; 210: 930–2.
39. Walter V, Jansen L, Hoffmeister M, et al. Smoking and survival of colorectal cancer patients: population-based study from Germany. Int J Cancer 2015; 137: 1433–45.
40. Auvinen A. Social class and colon cancer survival in Finland. Cancer 1992; 70: 402–9.
41. Lee W, Nelson R, Mailey B, et al. Socioeconomic factors impact colon cancer outcomes in diverse patient populations. J Gastrointest Surg 2012; 16: 692–704.
42. Yim J, Hwang S-S, Yoo K-Y, et al. Contribution of income-related inequality and healthcare utilisation to survival in cancers of the lung, liver, stomach and colon. J Epidemiol Community Health 2012; 66: 37–40.
43. Haustein K-O. Smoking and poverty. Eur J Cardio Prev Rehab 2006; 13: 312–8.
44. Brugha R, Tully N, Dicker P, et al. SLÁN 2007: Survey of Lifestyle, Attitudes and Nutrition in Ireland. Smoking Patterns in Ireland: Implications for Policy and Services. Dublin: Department of Health & Children, The Stationery Office, 2009.
45. Suissa S. Immortal time bias in pharmacoepidemiology. Am J Epidemiol 2008; 167: 492–9.
46. Cuffy M, Abir F, Audisio RA, et al. Colorectal cancer presenting as surgical emergencies. Surg Oncol 2004; 13: 149–57.
47. National Cancer Intelligence Unit. Routes to Diagnosis: Exploring Emergency Presentations NCIN Data Briefing. London: National Cancer Intelligence Unit, 2013.
48. Gunnarsson H, Ekholm A, Olsson LI. Emergency presentation and socioeconomic status in colon cancer. Eur J Surg Oncol 2013; 39: 831–6.
49. Amri R, Bordeianou LG, Sylla P, et al. Colon cancer surgery following emergency presentation: effects on admission and stage-adjusted outcomes. Am J Surg 2015; 209: 246–53.
50. Amri R, Bordeianou LG, Sylla P, et al. Association of radial margin positivity with colon cancer. JAMA Surg 2015; 150: 890–8.
51. Yanbaeva DG, Dentener MA, Creutzberg EC, et al. Systemic effects of smoking. CHEST J 2007; 131: 1557–66.
52. Richards CH, Platt JJ, Anderson JH, et al. The impact of perioperative risk, tumor pathology and surgical complications on disease recurrence following potentially curative resection of colorectal cancer. Ann Surg 2011; 254: 83–9.
53. Thirunavukarasu P, Talati C, Munjal S, et al. Effect of incorporation of pretreatment serum carcinoembryonic antigen levels into AJCC staging for colon cancer on 5-year survival. JAMA Surg 2015; 150: 747–55.
54. Herbeth B, Bagrel A. A study of factors influencing plasma CEA levels in an unselected population. Oncodev Biol Med 1979; 1: 191–8.
55. Wilson AP, Van Dalen A, Sibley PE, et al. Multicentre tumour marker reference range study. Anticancer Res 1998; 19: 2749–52.
56. Longnecker MP, Clapp RW, Sheahan K. Associations between smoking status and stage of colorectal cancer at diagnosis in Massachusetts between 1982 and 1987. Cancer 1989; 64: 1372–4.
57. Yeager DS, Krosnick JA. The validity of self-reported nicotine product use in the 2001–2008 National Health and Nutrition Examination Survey. Med Care 2010; 48: 1128–32.
58. Roulson J-A, Benbow EW, Hasleton PS. Discrepancies between clinical and autopsy diagnosis and the value of post mortem histology; a meta-analysis and review. Histopathology 2005; 47: 551–9.
59. Berg CJ, Thomas AN, Mertens AC, et al. Correlates of continue smoking versus cessation among survivors of smoking-related cancers. Psychooncology 2013; 22: 799–806.
60. Bryant J, Boyes AW, Halll A, Girgis A, D'Este C, Sitas F. Prevalence and factors related to smoking and smoking cessation 6 months following a cancer diagnosis: a population-based study. J Cancer Surviv 2016; 10: 645–53.
61. Gritz ER, Fingeret MC, Vidrine DJ, Lazev AB, Mehta NV, Reece GP. Successes and failures of the teachable moment: smoking cessation in cancer patients. Cancer 2006; 106: 12–27.
62. McCarter K, Martinez U, Britton B, et al. Smoking cessation among patients with head and neck cancer: a systematic review. BMJ Open 2016; 6: e012296.
63. Sorensen LT, Jorgensen T. Short-term pre-operative smoking cessation intervention does not affect postoperative complications in colorectal surgery: a randomized clinical trial. Colorect Dis 2003; 5: 347–52.